Laboratory Software Articles & Analysis
94 news found
Rivaz directs the IMage Processing and Characterization of Tissue (IMPACT) laboratory at Concordia University and is also an associate editor of IEEE Transactions on Medical Imaging. ...
This week, Thermo Fisher Scientific will highlight its investments and innovations over the past 12 months across its global pharma services network, which have been focused on areas of accelerated demand including cell and gene therapy, drug product development, biologics manufacturing and clinical supply chain services. These highlights will be showcased this week at Virtual DCAT Week. "This ...
"Our MAS Quality Control products help clinical laboratories maximize productivity with market-leading consolidation of control material, shelf-life stability longer than industry standard and open vial stability that reduces the cost and time required for recalibrating new lots," said Tina Liedtky, president of clinical diagnostics for Thermo Fisher Scientific. "Our continued ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Alan Sachs, who has served as chief scientific officer (CSO) since 2016, will assume the newly established role of chief medical officer (CMO) and will be succeeded by Karen E. Nelson, previously president of the J. Craig Venter Institute. Both will join the company leadership team in August 2021. ...
For gene therapy developers seeking to rapidly and efficiently scale production, a set of solutions is now available from Thermo Fisher Scientific to support adeno-associated viral (AAV) manufacturing. A new media panel, gene kit and advanced purification resins help reduce manufacturing costs while increasing the viability of gene therapies as treatment options for patients. AAV is a ...
Thermo Fisher Scientific, the world leader in serving science, today announced the launch of a new CE-IVD-marked COVID-19 test. The TaqPath COVID-19 Fast PCR Combo Kit 2.0. expands Thermo Fisher's menu of highly accurate tests that detect active SARS-CoV-2 infections. The kit uses an advanced assay design which compensates for current and emerging variants by using eight total targets across ...
BIO DIGITAL 2021 – New and emerging biopharma companies working on early development can now leverage a better lab to clinic drug development solution designed to accelerate the journey from DNA to drug product. The enhanced Quick to Clinic solution from Thermo Fisher Scientific may help biopharma companies reach Phase I/First-In-Human trials and file for Investigational New Drug (IND) ...
The companies will highlight the strengths of their technologies when coupled for protein analysis to provide laboratories with new and advanced biopharmaceutical capabilities that will enable greater insight into results generated by Imaged Capillary Isoelectric Focusing (iCIEF) protein separation. ...
Thermo Fisher Scientific today introduced the Ion AmpliSeq SARS-CoV-2 Insight Research Assay to improve SARS-CoV-2 surveillance. The assay is designed to enable early identification of new and known variants from samples that have lower viral loads. By sequencing more than 99 percent of the SARS-CoV-2 genome, the assay covers all potential serotypes. The new Ion AmpliSeq SARS-CoV-2 Insight ...
Thermo Fisher Scientific, the world leader in serving science, today announced that its TaqPath COVID-19 CE-IVD RT PCR Kit has been independently validated as meeting the performance characteristics for the Day 2 and Day 8 COVID-19 quarantine protocol testing required for international travellers arriving in the United Kingdom. The United Kingdom has instituted quarantine rules for travellers ...
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and the University of California, San Francisco (UCSF) today announced they have formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies. Under the agreement, Thermo Fisher will build and operate a 44,000-square-foot, state-of-the-art cell therapy development, manufacturing ...
Samples are collected using a single or pooled swab format and will be sent to certified labs at Dayton Children's Hospital, Ohio State University and Ohio Department of Health laboratories. The program is being funded by Gov. DeWine and the Ohio Department of Health, using money allocated by the Biden Administration to help states administer screening testing programs in support ...
Thermo Fisher Scientific Inc. has made a donation to the Leukemia & Lymphoma Society in recognition of the recent U.S. Food and Drug Administration approval of the first CAR T cell immunotherapy for multiple myeloma developed by Bristol Myers Squibb and bluebird bio. Abecma® (idecabtagene vicleucel; ide-cel) is a chimeric antigen receptor (CAR) T cell immunotherapy for the treatment of ...
Establishes Thermo Fisher as a global leader in the attractive and high growth clinical research services industry Adds highly complementary services for the company's fastest growing end market Offers both meaningful cost and revenue synergies which will further accelerate growth Expected to be immediately and significantly accretive to Adjusted Earnings Per Share (EPS)¹ after close ...
Amplitude Solution with TaqPath COVID-19 High-Throughput Combo Kit enables labs to scale high-sensitivity PCR testing The Amplitude Solution enables clinical and public health laboratories to scale gold standard PCR testing and process up to 8,000 samples in a single day with minimal staffing resources and a secured supply of kits, reagents and consumables to meet their testing ...
The innovative product enables clinical laboratories and assay developers to meet testing demands and enhance their molecular diagnostics workflows. Clinical diagnostic and hospital laboratories across the United States have ramped up PCR testing over the last year in response to the global COVID-19 pandemic. These laboratories are now seeking ...
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the launch of the Thermo Scientific AerosolSense Sampler, a new surveillance solution designed to deliver fast and highly reliable insight into the presence of in-air pathogens, including SARS-CoV-2. ...
Thermo Fisher Scientific, the world leader in serving science, and Artificial, developers of flexible automation software, have announced a strategic technology collaboration to develop an integrated and comprehensive software automation platform for Thermo Fisher's standardized COVID-19 Testing Platform. ...
Thermo Fisher Scientific today launched the new Gibco Human Plasma-like Medium (HPLM), the first cell culture medium on the market that mimics the metabolic profile of human plasma that is designed to provide researchers with a realistic view of cell growth within the human body. Gibco HPLM contains the same salt concentrations found in human plasma, as well as the same concentrations of over 60 ...
Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel, a customizable menu of 22 verified real-time PCR assays for identification of SARS-CoV-2 mutations. These assays enable surveillance of variants that are causing COVID-19 infections in specific regions globally and allow laboratories to choose which ...